{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:51:47Z","timestamp":1791546707468,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373871"],"award-info":[{"award-number":["82373871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77133-8","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:13:50Z","timestamp":1788887630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision inflammation targeting via myeloperoxidase mediated antioxidant melanin nanomedicines for chronic inflammation therapy"],"prefix":"10.1038","volume":"17","author":[{"given":"Yiming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-5961","authenticated-orcid":false,"given":"Qiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9863-8963","authenticated-orcid":false,"given":"Kelong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"77133_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari, A. J. et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2133\u20132161 (2024).","journal-title":"Lancet"},{"key":"77133_CR2","unstructured":"Pahwa, R., Goyal, A. & Jialal, I. Chronic Inflammation. in StatPearls (2024)."},{"key":"77133_CR3","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822\u20131832 (2019).","journal-title":"Nat. Med."},{"key":"77133_CR4","doi-asserted-by":"publisher","unstructured":"Hoffman, D. Commentary on chronic Disease Prevention in the US in 2022. Ann. Bioethics Clin. App. 5, https:\/\/doi.org\/10.23880\/abca-16000231 (2022).","DOI":"10.23880\/abca-16000231"},{"key":"77133_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","volume":"12","author":"A Louvet","year":"2015","unstructured":"Louvet, A. & Mathurin, P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat. Rev. Gastroenterol. Hepatol. 12, 231\u2013242 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"77133_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-022-00604-y","volume":"19","author":"EJ Villablanca","year":"2022","unstructured":"Villablanca, E. J., Selin, K. & Hedin, C. R. H. Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?. Nat. Rev. Gastroenterol. Hepatol. 19, 493\u2013507 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"77133_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","volume":"15","author":"N Jourde-Chiche","year":"2019","unstructured":"Jourde-Chiche, N. et al. Endothelium structure and function in kidney health and disease. Nat. Rev. Nephrol. 15, 87\u2013108 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"77133_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41577-022-00694-4","volume":"22","author":"J Amersfoort","year":"2022","unstructured":"Amersfoort, J., Eelen, G. & Carmeliet, P. Immunomodulation by endothelial cells \u2014 partnering up with the immune system?. Nat. Rev. Immunol. 22, 576\u2013588 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"77133_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20905-1","volume":"12","author":"LS Tombor","year":"2021","unstructured":"Tombor, L. S. et al. Single cell sequencing reveals endothelial plasticity with transient mesenchymal activation after myocardial infarction. Nat. Commun. 12, 681 (2021).","journal-title":"Nat. Commun."},{"key":"77133_CR10","doi-asserted-by":"crossref","unstructured":"Uchimido, R., Schmidt, E. P. & Shapiro, N. I. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit. Care 23, 16 (2019).","DOI":"10.1186\/s13054-018-2292-6"},{"key":"77133_CR11","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm.2843","volume":"18","author":"EP Schmidt","year":"2012","unstructured":"Schmidt, E. P. et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat. Med. 18, 1217\u20131223 (2012).","journal-title":"Nat. Med."},{"key":"77133_CR12","doi-asserted-by":"publisher","unstructured":"Park, S. et al. Collagen mineralization decreases NK cell-mediated cytotoxicity of breast cancer cells via Increased Glycocalyx Thickness. Adv. Mater. 36,https:\/\/doi.org\/10.1002\/adma.202311505 (2024).","DOI":"10.1002\/adma.202311505"},{"key":"77133_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201910-1911TR","volume":"202","author":"J Joffre","year":"2020","unstructured":"Joffre, J., Hellman, J., Ince, C. & Ait-Oufella, H. Endothelial responses in sepsis. Am. J. Respir. Crit. Care Med 202, 361\u2013370 (2020).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"77133_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.it.2019.03.009","volume":"40","author":"GJ Graham","year":"2019","unstructured":"Graham, G. J., Handel, T. M. & Proudfoot, A. E. I. Leukocyte adhesion: reconceptualizing chemokine presentation by glycosaminoglycans. Trends Immunol. 40, 472\u2013481 (2019).","journal-title":"Trends Immunol."},{"key":"77133_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.freeradbiomed.2021.07.007","volume":"172","author":"CL Hawkins","year":"2021","unstructured":"Hawkins, C. L. & Davies, M. J. Role of myeloperoxidase and oxidant formation in the extracellular environment in inflammation-induced tissue damage. Free Radic. Biol. Med. 172, 633\u2013651 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"77133_CR16","doi-asserted-by":"publisher","first-page":"107685","DOI":"10.1016\/j.pharmthera.2020.107685","volume":"218","author":"MJ Davies","year":"2021","unstructured":"Davies, M. J. Myeloperoxidase: Mechanisms, reactions and inhibition as a therapeutic strategy in inflammatory diseases. Pharmacol. Ther. 218, 107685 (2021).","journal-title":"Pharmacol. Ther."},{"key":"77133_CR17","doi-asserted-by":"publisher","first-page":"102109","DOI":"10.1016\/j.redox.2021.102109","volume":"46","author":"AG Siraki","year":"2021","unstructured":"Siraki, A. G. The many roles of myeloperoxidase: From inflammation and immunity to biomarkers, drug metabolism and drug discovery. Redox Biol. 46, 102109 (2021).","journal-title":"Redox Biol."},{"key":"77133_CR18","doi-asserted-by":"crossref","unstructured":"Klinke, A. et al. Myeloperoxidase aggravates pulmonary arterial hypertension by activation of vascular Rho-kinase. JCI Insight 3, e97530 (2018).","DOI":"10.1172\/jci.insight.97530"},{"key":"77133_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2020.11.008","volume":"162","author":"H Kolarova","year":"2021","unstructured":"Kolarova, H. et al. Myeloperoxidase mediated alteration of endothelial function is dependent on its cationic charge. Free Radic. Biol. Med. 162, 14\u201326 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"77133_CR20","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1182\/blood-2010-05-284513","volume":"117","author":"A Klinke","year":"2011","unstructured":"Klinke, A. et al. Myeloperoxidase attracts neutrophils by physical forces. Blood 117, 1350\u20131358 (2011).","journal-title":"Blood"},{"key":"77133_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1021\/jacs.6b11013","volume":"139","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Comprehensive insights into the multi-antioxidative mechanisms of melanin nanoparticles and their application to protect brain from injury in ischemic stroke. J. Am. Chem. Soc. 139, 856\u2013862 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"77133_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","volume":"140","author":"L Rochette","year":"2013","unstructured":"Rochette, L. et al. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?. Pharmacol. Ther. 140, 239\u2013257 (2013).","journal-title":"Pharmacol. Ther."},{"key":"77133_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcb.2015.12.002","volume":"26","author":"H Blaser","year":"2016","unstructured":"Blaser, H., Dostert, C., Mak, T. W. & Brenner, D. TNF and ROS crosstalk in inflammation. Trends Cell Biol. 26, 249\u2013261 (2016).","journal-title":"Trends Cell Biol."},{"key":"77133_CR24","doi-asserted-by":"crossref","unstructured":"Liu, J. et al. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy. J. Hematol. Oncol. 16, 116 (2023).","DOI":"10.1186\/s13045-023-01512-7"},{"key":"77133_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrgastro.2012.123","volume":"9","author":"J Zhang","year":"2012","unstructured":"Zhang, J. & Fallon, M. B. Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat. Rev. Gastroenterol. Hepatol. 9, 539\u2013549 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"77133_CR26","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","volume":"100","author":"MJ Krowka","year":"2016","unstructured":"Krowka, M. J. et al. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation 100, 1440\u20131452 (2016).","journal-title":"Transplantation"},{"key":"77133_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2017.11.012","volume":"104","author":"CT Shearn","year":"2018","unstructured":"Shearn, C. T., Orlicky, D. J. & Petersen, D. R. Dysregulation of antioxidant responses in patients diagnosed with concomitant primary sclerosing cholangitis\/inflammatory bowel disease. Exp. Mol. Pathol. 104, 1\u20138 (2018).","journal-title":"Exp. Mol. Pathol."},{"key":"77133_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155942","volume":"159","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. The mitochondrial TSPO ligand Atriol mitigates metabolic-associated steatohepatitis by downregulating CXCL1. Metab. Clin. Exp. 159, 155942 (2024).","journal-title":"Metab. Clin. Exp."},{"key":"77133_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","volume":"157","author":"R Brusini","year":"2020","unstructured":"Brusini, R., Varna, M. & Couvreur, P. Advanced nanomedicines for the treatment of inflammatory diseases. Adv. Drug Deliv. Rev. 157, 161\u2013178 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"77133_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","volume":"9","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal Transduct. Target Ther. 9, 34 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"77133_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jhep.2012.05.014","volume":"57","author":"J Zhang","year":"2012","unstructured":"Zhang, J. et al. The role of CX(3)CL1\/CX(3)CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J. Hepatol. 57, 752\u2013758 (2012).","journal-title":"J. Hepatol."},{"key":"77133_CR32","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1002\/hep.30079","volume":"68","author":"S Raevens","year":"2018","unstructured":"Raevens, S. & Fallon, M. B. Potential clinical targets in hepatopulmonary syndrome: lessons from experimental models. Hepatology 68, 2016\u20132028 (2018).","journal-title":"Hepatology"},{"key":"77133_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","volume":"4","author":"MP Murphy","year":"2022","unstructured":"Murphy, M. P. et al. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat. Metab. 4, 651\u2013662 (2022).","journal-title":"Nat. Metab."},{"key":"77133_CR34","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/j.cell.2022.06.038","volume":"185","author":"CG Weindel","year":"2022","unstructured":"Weindel, C. G. et al. Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis. Cell 185, 3214\u20133231 (2022).","journal-title":"Cell"},{"key":"77133_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1172\/JCI82585","volume":"126","author":"K Hu","year":"2016","unstructured":"Hu, K. & Olsen, B. R. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J. Clin. Investig. 126, 509\u2013526 (2016).","journal-title":"J. Clin. Investig."},{"key":"77133_CR36","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-16-2706","volume":"77","author":"D Huang","year":"2017","unstructured":"Huang, D. et al. Epstein\u2013barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages. Cancer Res. 77, 3591\u20133604 (2017).","journal-title":"Cancer Res."},{"key":"77133_CR37","doi-asserted-by":"publisher","first-page":"G72","DOI":"10.1152\/ajpgi.00178.2013","volume":"306","author":"W Yang","year":"2014","unstructured":"Yang, W. et al. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G72\u2013G80 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"77133_CR38","doi-asserted-by":"publisher","first-page":"173008","DOI":"10.1016\/j.ejphar.2020.173008","volume":"873","author":"AG Bakr","year":"2020","unstructured":"Bakr, A. G., El-Bahrawy, A. H., Taha, H. H. & Ali, F. E. M. Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-alpha\/VEGF, IGF-1\/PI3K\/AKT, and FGF-1\/ANG-2 signaling pathways. Eur. J. Pharm. 873, 173008 (2020).","journal-title":"Eur. J. Pharm."},{"key":"77133_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110309","volume":"38","author":"CS Mantsounga","year":"2022","unstructured":"Mantsounga, C. S. et al. Macrophage IL-1\u03b2 promotes arteriogenesis by autocrine STAT3- and NF-\u03baB-mediated transcription of pro-angiogenic VEGF-A. Cell Rep. 38, 110309 (2022).","journal-title":"Cell Rep."},{"key":"77133_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02731-y","volume":"20","author":"C Yi","year":"2023","unstructured":"Yi, C. et al. Old age promotes retinal fibrosis in choroidal neovascularization through circulating fibrocytes and profibrotic macrophages. J. Neuroinflamm. 20, 45 (2023).","journal-title":"J. Neuroinflamm."},{"key":"77133_CR41","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.ajpath.2014.02.027","volume":"184","author":"J Zhang","year":"2014","unstructured":"Zhang, J., Yang, W., Hu, B., Wu, W. & Fallon, M. B. Endothelin-1 activation of the endothelin B receptor modulates pulmonary endothelial CX3CL1 and contributes to pulmonary angiogenesis in experimental hepatopulmonary syndrome. Am. J. Pathol. 184, 1706\u20131714 (2014).","journal-title":"Am. J. Pathol."},{"key":"77133_CR42","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1002\/hep.31545","volume":"73","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. The apelin\u2013apelin receptor axis triggers cholangiocyte proliferation and liver fibrosis during mouse models of cholestasis. Hepatology 73, 2411\u20132428 (2021).","journal-title":"Hepatology"},{"key":"77133_CR43","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich, L. & Tacke, F. Hepatic inflammatory responses in liver fibrosis. Nat. Rev. Gastroenterol. Hepatol. 20, 633\u2013646 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"77133_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32575-8","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice. Nat. Commun. 13, 5111 (2022).","journal-title":"Nat. Commun."},{"key":"77133_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310731","volume":"36","author":"Y Kong","year":"2024","unstructured":"Kong, Y. et al. Ultrasmall polyphenol-NAD(+) nanoparticle-mediated renal delivery for mitochondrial repair and anti-inflammatory treatment of AKI-to-CKD progression. Adv. Mater. 36, e2310731 (2024).","journal-title":"Adv. Mater."},{"key":"77133_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409015","volume":"36","author":"M Liang","year":"2024","unstructured":"Liang, M. et al. Polypyridiniums with inherent autophagy-inducing activity for atherosclerosis treatment by intracellularly co-delivering two antioxidant enzymes. Adv. Mater. 36, e2409015 (2024).","journal-title":"Adv. Mater."},{"key":"77133_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang, R. H., Gao, W. & Zhang, L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat. Rev. Clin. Oncol. 20, 33\u201348 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"77133_CR48","doi-asserted-by":"publisher","unstructured":"Song, D., Zhao, Y., Wang, Z. & Xu, Q. Tuning lipid nanoparticles for RNA delivery to extrahepatic organs. Adv. Mater. 36,https:\/\/doi.org\/10.1002\/adma.202401445 (2024).","DOI":"10.1002\/adma.202401445"},{"key":"77133_CR49","doi-asserted-by":"crossref","unstructured":"Xing, Y. et al. Lysosome targeted nanoparticle aggregation reverses immunosuppressive tumor microenvironment for cancer immunotherapy. Adv. Mater. 36, e2412730 (2024).","DOI":"10.1002\/adma.202412730"},{"key":"77133_CR50","doi-asserted-by":"crossref","unstructured":"Vaidya, A. et al. Expanding RNAi to kidneys, lungs, and spleen via selective Organ targeting (SORT) siRNA lipid nanoparticles. Adv. Mater. 36, e2313791 (2024).","DOI":"10.1002\/adma.202313791"},{"key":"77133_CR51","doi-asserted-by":"crossref","unstructured":"Robert, F. et al. Disrupted BMP-9 signaling impairs pulmonary vascular integrity in hepatopulmonary syndrome. Am. J. Respir. Crit. Care. Med. 210, 648\u2013661 (2024).","DOI":"10.1164\/rccm.202307-1289OC"},{"key":"77133_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1042\/CS20160593","volume":"131","author":"X Li","year":"2017","unstructured":"Li, X. et al. CXCR2 is involved in pulmonary intravascular macrophage accumulation and angiogenesis in a rat model of hepatopulmonary syndrome. Clin. Sci. 131, 159\u2013168 (2017).","journal-title":"Clin. Sci."},{"key":"77133_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2023.03.018","volume":"79","author":"S Baweja","year":"2023","unstructured":"Baweja, S. et al. Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. J. Hepatol. 79, 167\u2013180 (2023).","journal-title":"J. Hepatol."},{"key":"77133_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1042\/CS20120052","volume":"124","author":"CC Chang","year":"2013","unstructured":"Chang, C. C. et al. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. Clin. Sci. 124, 457\u2013466 (2013).","journal-title":"Clin. Sci."},{"key":"77133_CR55","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/lt.25438","volume":"25","author":"SM Kawut","year":"2019","unstructured":"Kawut, S. M. et al. Sorafenib in hepatopulmonary syndrome: a randomized, double-blind, placebo-controlled trial. Liver Transplant. 25, 1155\u20131164 (2019).","journal-title":"Liver Transplant."},{"key":"77133_CR56","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","volume":"19","author":"M Agrawal","year":"2022","unstructured":"Agrawal, M., Allin, K. H., Petralia, F., Colombel, J.-F. & Jess, T. Multiomics to elucidate inflammatory bowel disease risk factors and pathways. Nat. Rev. Gastroenterol. Hepatol. 19, 399\u2013409 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"77133_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","volume":"71-72","author":"J Liu","year":"2023","unstructured":"Liu, J., Di, B. & Xu, L. -l Recent advances in the treatment of IBD: Targets, mechanisms and related therapies. Cytokine Growth Factor Rev. 71-72, 1\u201312 (2023).","journal-title":"Cytokine Growth Factor Rev."},{"key":"77133_CR58","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang, J. T. Pathophysiology of inflammatory bowel diseases.  N. Engl. J. Med. 383, 2652\u20132664 (2020).","journal-title":"N. Engl. J. Med."},{"key":"77133_CR59","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2021.10.037","volume":"162","author":"S Ben-Horin","year":"2022","unstructured":"Ben-Horin, S. et al. Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease: a systematic review and an individual-patient data meta-analysis of randomized controlled trials. Gastroenterology 162, 482\u2013494 (2022).","journal-title":"Gastroenterology"},{"key":"77133_CR60","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/j.cgh.2021.03.034","volume":"20","author":"W Ahmed","year":"2022","unstructured":"Ahmed, W. et al. Dual biologic or small molecule therapy for treatment of inflammatory bowel disease: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 20, e361\u2013e379 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"77133_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejpb.2022.01.009","volume":"172","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung. Eur. J. Pharm. Biopharm. 172, 101\u2013111 (2022).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"77133_CR62","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941\u2013951 (2015).","journal-title":"Nat. Biotechnol."},{"key":"77133_CR63","doi-asserted-by":"publisher","unstructured":"Luna-Marco, C. et al. Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes. Redox Biol. 66,https:\/\/doi.org\/10.1016\/j.redox.2023.102849 (2023).","DOI":"10.1016\/j.redox.2023.102849"},{"key":"77133_CR64","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1089\/ars.2019.7971","volume":"32","author":"CJA Ramachandra","year":"2020","unstructured":"Ramachandra, C. J. A. et al. Myeloperoxidase as a multifaceted target for cardiovascular protection. Antioxid. Redox Signal. 32, 1135\u20131149 (2020).","journal-title":"Antioxid. Redox Signal."},{"key":"77133_CR65","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.123.067931","volume":"150","author":"S Shamsuzzaman","year":"2024","unstructured":"Shamsuzzaman, S. et al. Novel mouse model of myocardial infarction, plaque rupture, and stroke shows improved survival with myeloperoxidase inhibition. Circulation 150, 687\u2013705 (2024).","journal-title":"Circulation"},{"key":"77133_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202412097","volume":"21","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Wu, S., Zoppellaro, G., Ba\u010fura, Z. & Schmuki, P. Platinum single atoms strongly promote superoxide formation in titania-based photocatalysis - platinum nanoparticles don\u2019t. Small 21, e2412097 (2025).","journal-title":"Small"},{"key":"77133_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2024.124967","volume":"324","author":"R Raja","year":"2025","unstructured":"Raja, R. et al. Colorimetric detection of Cr(VI) in water using tetramethyl benzidine (TMB) as an indicator. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 324, 124967 (2025).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"77133_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50854-4","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Reprogramming the myocardial infarction microenvironment with melanin-based composite nanomedicines in mice. Nat. Commun. 15, 6651 (2024).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77133-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77133-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77133-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:02:47Z","timestamp":1791543767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77133-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77133"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77133-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4623322\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests, financial or otherwise.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10626"}}